DiscoverCleveland Clinic Cancer AdvancesEvolving Frontline Therapy for Chronic Lymphocytic Leukemia (CLL)
Evolving Frontline Therapy for Chronic Lymphocytic Leukemia (CLL)

Evolving Frontline Therapy for Chronic Lymphocytic Leukemia (CLL)

Update: 2025-05-15
Share

Description

Brian T. Hill, MD, PhD, Director of the Lymphoid Malignancies Program at Cleveland Clinic, joins the Cancer Advances Podcast to talk about the latest updates in first-line therapy for chronic lymphocytic leukemia (CLL). During this episode, Dr. Hill explains the shift from traditional chemoimmunotherapy to more precise, targeted treatments, and how customized therapy is transforming patient outcomes.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Evolving Frontline Therapy for Chronic Lymphocytic Leukemia (CLL)

Evolving Frontline Therapy for Chronic Lymphocytic Leukemia (CLL)

Cleveland Clinic Taussig Cancer Institute